ISPOR Europe 2021

ISPOR Europe 2021

ISPOR Europe 2021

Venez assister aux communications de congrès de l’ISPOR Europe 2021 pour découvrir les 5 posters réalisés en collaboration avec CEMKA :

  • Effectiveness of caplacizumab on reducing acute mortality in acquired thrombotic thrombocytopenic purpura: results from a french national registry (CNR-MAT)
  • Cost-effectiveness of atezolizumab in association with bevacizumab for patients with untreated locally advanced or metastatic hepatocellular carcinoma (HCC) using a french real-world evidence database
  • Prevalence of prurigo nodularis in the regional area of Brittany (France): estimation by matching two databases
  • Health economic impact of phenylketonuria – A retrospective claims database study in France
  • Cost-effectiveness analysis of neisvac® to prevent C-IMD in children and young people in France